Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancerR I Lalisang, J A Wils, H W Nortier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 7, 1999
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiationJ J Jager, L Volovics, L J Schouten, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancerJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.
Breast Cancer Research and Treatment|January 1, 1996
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.
British Journal of Cancer|June 23, 2000
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancerR I Lalisang, E E Voest, J A Wils, et al.
Anticancer Research|May 16, 2000
Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancerJ J Jager, R L Jansen, J W Arends, et al.
Pageof 11